MedPath

云鹏医药集团有限公司

Ownership
-
Established
1998-09-15
Employees
-
Market Cap
-
Website
www.ypyyjt.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

179

NMPA:179

Drug Approvals

Etoricoxib Tablets

Product Name
依托考昔片
Approval Number
国药准字H20254038
Approval Date
Apr 30, 2025
NMPA

Etoricoxib Tablets

Product Name
依托考昔片
Approval Number
国药准字H20254037
Approval Date
Apr 30, 2025
NMPA

Lactulose Oral Solution

Product Name
乳果糖口服溶液
Approval Number
国药准字H20253657
Approval Date
Mar 18, 2025
NMPA

Azithromycin Tablets

Product Name
阿奇霉素片
Approval Number
国药准字H20093256
Approval Date
Apr 15, 2024
NMPA

Linezolid Tablets

Product Name
利奈唑胺片
Approval Number
国药准字H20243376
Approval Date
Mar 19, 2024
NMPA

Simvastatin Tablets

Product Name
辛伐他汀片
Approval Number
国药准字H20083592
Approval Date
May 29, 2023
NMPA

Simvastatin Tablets

Product Name
辛伐他汀片
Approval Number
国药准字H20083593
Approval Date
May 29, 2023
NMPA

Rosuvastatin Calcium Tablets

Product Name
瑞舒伐他汀钙片
Approval Number
国药准字H20233536
Approval Date
May 12, 2023
NMPA

Ibuprofen Sustained-release Capsules

Product Name
布洛芬缓释胶囊
Approval Number
国药准字H20123416
Approval Date
Sep 26, 2022
NMPA

Omeprazole Enteric-coated Tablets

Product Name
奥美拉唑肠溶片
Approval Number
国药准字H20123239
Approval Date
Jul 14, 2022
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 18
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.